| Canada exports to Pakistan · Acids: carboxylic acids, (with alcohol function but without other oxygen function), n.e.s. in item no. 2918.1 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Acids: carboxylic acids, (with alcohol function but without other oxygen function), n.e.s. in item no. 2918.1 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Amine-function compounds: acyclic polyamines and their derivatives, and salts thereof, n.e.s. in item no. 2921.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Amine-function compounds: cyclanic, cyclenic or cycloterpenic mono- or polyamines and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Amine-function compounds: aromatic monoamines and their derivatives, diphenylamine and its derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Amine-function compounds: aromatic monoamines and their derivatives, diphenylamine and its derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Other Asia, nes · Amine-function compounds: aromatic monoamines and their derivatives, diphenylamine and its derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Amine-function compounds: aromatic monoamines and their derivatives, diphenylamine and its derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Amine-function compounds: aromatic monoamines and their derivatives, diphenylamine and its derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Amine-function compounds: aromatic monoamines and their derivatives: salts thereof: n.e.s. in item no. 2921.4 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Amino-alcohols, their ethers and esters: (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.1 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Amino-naphthols and other amino-phenols: their ethers and esters, (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Amino-acids: their esters, (other than those containing more than one kind of oxygen function), n.e.s. in item no. 2922.4 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Lecithins and other phosphoaminolipids | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Quaternary ammonium salts and hydroxides: n.e.s. in heading no. 2923 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Cyclic amides (including cyclic carbamates) and their derivatives: n.e.s. in item no. 2924.2 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Organo-sulphur compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Spain · Organo-inorganic compounds: n.e.s. in heading no. 2930 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused furan ring (whether or not hydrogenated) in the structure, tetrahydrofuran | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused furan ring (whether or not hydrogenated) in the structure, n.e.s. in item no. 2932.10 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Heterocyclic compounds: lactones, other lactones excluding those of item no. 2932.21 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2932 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Heterocyclic compounds: n.e.s. in heading no. 2932 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Chile · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Heterocyclic compounds: n.e.s. in heading no. 2933 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Heterocyclic compounds: containing an unfused thiazole ring (whether or not hydrogenated) in the structure | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Argentina · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Netherlands · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to New Zealand · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Poland · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Heterocyclic compounds: n.e.s. in chapter 29 | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: D- or DL-pantothenic acid (vitamin B3 or vitamin B5) and its derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Vitamins: vitamin B12 and its derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones: cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Hormones: halogenated derivatives or adrenal cortical hormones | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Alkaloids, vegetable: theophylline and aminophylline (theophyllineethylenediamine) and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Antibiotics: tetracyclines and their derivatives: salts thereof | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Finland · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Italy · Blood: human and animal, antisera and other blood fractions | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Chile · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Costa Rica · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Dominican Rep. · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Barbados · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Bermuda · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Peru · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Kingdom · Vaccines: for human medicine | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Finland · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Hungary · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Ireland · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Austria · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Other Asia, nes · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Brazil · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to USA · Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Australia · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Israel · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to India · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Spain · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Saint Kitts and Nevis · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Saint Vincent and the Grenadines · Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Chile · Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Rep. of Korea · Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Macao SAR · Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Mexico · Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Saint Vincent and the Grenadines · Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to China, Hong Kong SAR · Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Thailand · Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Belize · Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to France · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Israel · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Bahrain · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Singapore · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Switzerland · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to United Arab Emirates · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Japan · Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Colombia · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Dominica · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Germany · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |
| Canada exports to Guyana · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Canada | USD | Annual | 2024-01-01 | CEPII |